Company overview
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing ICCC with another company.
| Daily close (USD) | $9.75 |
| Market capitalization (USD) | $88,551,420.75 |
| Price / earnings (TTM) | Not reported |
| Price / book | 2.82 |
No matching rows. Clear the filter to see all records.
Read ICCC's valuation metrics
Company size
Immucell Corp's recorded market capitalization is $88,551,420.75. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
ICCC's recorded price-to-book ratio is 2.82. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Immucell Corp with Aurora
Use the snapshot above to ask a specific question about ICCC. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow ICCC's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.